
Opinion|Videos|February 5, 2024
Medication Assistance Programs Mitigating Financial Burden For Patients Receiving Bispecific Therapy
Experts underscore cost relief of bispecific antibodies via medication assistance programs.
Advertisement
The following is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Kirollos Hanna, PharmD, BCPS, BCOP, FACCC; Sarah Rockwell, PharmD, BCOP; Melody Chang, RPh, MBA, BCOP; and Ryan Cain, PA-C.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC
3
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
4
Jury Still Out on Testosterone Benefit to Menopause
5














































